REQUEST A DEMO
Total
USD $0.00
Search more companies

Biokinetica S.A. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Biokinetica S.A. Profile Updated: August 31, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Biokinetica is a company with over 20 years of experience in early phase clinical studies and drug development, including biosimilars. The company offers services for clinical trials, pharmaceutical IP, and research projects in oncological diseases. Biokinetica collaborates with pharma and biotech companies, as well as CROs, to implement their projects. The company's Clinical Center is equipped for First in Man studies with cardiological monitoring, and they have a recruitment team for healthy volunteers and patients for clinical studies.

Headquarters
Ul. Nadwislanska 37
Jozefow; Mazowieckie; Postal Code: 05-410

Contact Details: Purchase the Biokinetica S.A. report to view the information.

Website: http://www.biokinetica.com

Basic Information
Total Employees:
Purchase the Biokinetica S.A. report to view the information.
Outstanding Shares:
Purchase the Biokinetica S.A. report to view the information.
Registered Capital:
Purchase the Biokinetica S.A. report to view the information.
Incorporation Date:
September 08, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Biokinetica S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-0.8%
Total operating revenue
-0.6%
Operating profit (EBIT)
104.3%
EBITDA
98.75%
Net Profit (Loss) for the Period
35.94%
Total assets
47.43%
Total equity
27.69%
Operating Profit Margin (ROS)
9.56%
Net Profit Margin
3.04%
Return on Equity (ROE)
1.32%
Quick Ratio
-3.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?